Phazyme Capsule, Gelatin Coated
Pricing Report NDC 0132-0211-12

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Phazyme (NDC 0132-0211-12) is $0.25810 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Nov 19, 2025.

As a a human over the counter drug provided by C.b. Fleet Company, Inc., this medication is distributed in a 1 BLISTER PACK in 1 BOX / 12 CAPSULE, GELATIN COATED in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.25810
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Nov 19, 2025
Billable Units
1 EA
Estimated Package Price
$0.26
Data Status
As of Jul 08, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
0132-0211-12
Description
1 BLISTER PACK in 1 BOX / 12 CAPSULE, GELATIN COATED in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jun 2024, the NADAC wholesale price for (NDC ) has moved within a range of $0.25214 to $0.25984 per EA. Over this 1 year and 5 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.2521 - $0.2598
Market Volatility
3.05% Variance
Latest Trend
0.25%
Date Unit Price Unit Source Method Rate
Nov 19, 2025 $0.25810 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Nov 19, 2025 $0.25810 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Oct 22, 2025 $0.25875 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Sep 17, 2025 $0.25214 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 20, 2025 $0.25667 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 23, 2025 $0.25417 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 18, 2025 $0.25448 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 21, 2025 $0.25322 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Mar 19, 2025 $0.25492 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Mar 19, 2025 $0.25492 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Feb 19, 2025 $0.25516 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jan 22, 2025 $0.25737 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Dec 18, 2024 $0.25800 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Nov 20, 2024 $0.25864 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Sep 18, 2024 $0.25984 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Sep 18, 2024 $0.25984 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Jun 19, 2024 $0.25706 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 19, 2024 $0.25706 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026